Commerce Bank
- SEC CIK
- 0001009076
- Latest filing
- Aug 12, 2026
CRVS holding history
Corvus Pharmaceuticals, Inc. in every 13F filed by Commerce Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −20,000−100.0% | Sold out | Holders |
| Q4 2025 | 20,000 | $154.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 20,000 | $147.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 20,000 | $80.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 20,000 | $63.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 20,000 | $107.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 20,000 | $105.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 20,000 | $36.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 20,000 | $35.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 20,000 | $35.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 20,000 | $29.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 20,000 | $45.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 20,000 | $18.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 20,000 | $17.0K | <0.1% | +20,000 | New | Holders |